ABB is a leading technology company. Its products and services can be used in automated manufacturing, providing digital solutions, electrification of industry and transport and enhancing productivity. It reports business under 4 segments - Electrification, Robotics & Discrete Automation, Process Automation and Motion. Electrification segment is responsible for the manufacture and sale of products and services, including low and medium voltage switchgear, control products, DIN rail components, wiring accessories and installation material for a plethora of applications. Robotics & Discrete Automation: This segment includes the machine and factory automation solutions from the business of B&R and a wide-ranging robotics solutions and applications suite. Process Automation: This provides control and plant optimization systems and automation products and solutions for optimizing the productivity of industrial processes. Motion:'The segment specializes in supplying motors, drives and generator products....
+See MoreSharpe-Lintner-Black CAPM alpha (Premium Members Only) Fama-French (1993) 3-factor alpha (Premium Members Only) Fama-French-Carhart 4-factor alpha (Premium Members Only) Fama-French (2015) 5-factor alpha (Premium Members Only) Fama-French-Carhart 6-factor alpha (Premium Members Only) Dynamic conditional 6-factor alpha (Premium Members Only) Last update: Saturday 21 February 2026
2023-08-07 12:29:00 Monday ET

Oxford macro professor Stephen Nickell and his co-authors delve into the trade-off between inflation and unemployment in the dual mandate of price stability
2020-04-10 11:33:00 Friday ET

Elon Musk envisions a bold fantastic future with his professional trifecta of lean startup enterprises SolarCity, SpaceX, and Tesla. Ashlee Vance (2015)
2019-08-04 08:26:00 Sunday ET

U.S. and Chinese trade negotiators hold constructive phone talks after Presidents Trump and Xi exchange reconciliatory gestures at the G20 summit in Japan.
2025-10-31 12:26:00 Friday ET

With respect to wider weight loss treatment and obesity treatment, the global market for GLP-1 medications now grows substantially to benefit more than 1 bi
2019-01-10 17:31:00 Thursday ET

The recent Bristol-Myers Squibb acquisition of American Celgene is the $90 billion biggest biotech deal in history. The resultant biopharma goliath would be
2019-02-25 12:41:00 Monday ET

Chicago financial economist Raghuram Rajan views communities as the third pillar of liberal democracy in addition to open markets and states. Rajan suggests